Neogen Co. (NASDAQ:NEOG) Director James L. Herbert sold 15,000 shares of Neogen stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $59.05, for a total transaction of $885,750.00. Following the transaction, the director now directly owns 671,484 shares of the company’s stock, valued at $39,651,130.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Neogen stock traded down $1.53 during trading hours on Thursday, hitting $56.87. The company had a trading volume of 1,105 shares, compared to its average volume of 183,357. The stock has a market cap of $3.04 billion, a price-to-earnings ratio of 47.02, a price-to-earnings-growth ratio of 5.24 and a beta of 1.33. Neogen Co. has a 1 year low of $50.60 and a 1 year high of $97.38.

Neogen (NASDAQ:NEOG) last released its quarterly earnings data on Tuesday, March 26th. The company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by ($0.02). The company had revenue of $97.70 million during the quarter, compared to analysts’ expectations of $102.55 million. Neogen had a net margin of 14.96% and a return on equity of 10.48%. Neogen’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period last year, the firm earned $0.32 earnings per share. On average, research analysts predict that Neogen Co. will post 1.12 earnings per share for the current year.

NEOG has been the subject of several research reports. Zacks Investment Research cut shares of Neogen from a “hold” rating to a “sell” rating in a research report on Wednesday, April 10th. Guggenheim initiated coverage on shares of Neogen in a research report on Thursday. They issued a “neutral” rating for the company. BidaskClub cut shares of Neogen from a “hold” rating to a “sell” rating in a research report on Wednesday. Craig Hallum raised shares of Neogen from a “hold” rating to a “buy” rating and set a $62.76 price objective for the company in a research report on Tuesday, March 19th. Finally, ValuEngine cut shares of Neogen from a “buy” rating to a “hold” rating in a research report on Wednesday, January 30th. Two analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $62.76.

Institutional investors have recently added to or reduced their stakes in the business. Creative Planning raised its holdings in shares of Neogen by 2.4% in the 1st quarter. Creative Planning now owns 7,554 shares of the company’s stock valued at $434,000 after purchasing an additional 174 shares in the last quarter. Arizona State Retirement System raised its holdings in shares of Neogen by 0.3% in the 1st quarter. Arizona State Retirement System now owns 80,344 shares of the company’s stock valued at $4,611,000 after purchasing an additional 272 shares in the last quarter. Manchester Capital Management LLC raised its holdings in shares of Neogen by 105.6% in the 1st quarter. Manchester Capital Management LLC now owns 590 shares of the company’s stock valued at $34,000 after purchasing an additional 303 shares in the last quarter. Captrust Financial Advisors raised its holdings in shares of Neogen by 47.0% in the 4th quarter. Captrust Financial Advisors now owns 970 shares of the company’s stock valued at $55,000 after purchasing an additional 310 shares in the last quarter. Finally, McCollum Christoferson Group LLC raised its holdings in shares of Neogen by 0.3% in the 1st quarter. McCollum Christoferson Group LLC now owns 124,921 shares of the company’s stock valued at $7,169,000 after purchasing an additional 334 shares in the last quarter. 88.81% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: “Insider Selling: Neogen Co. (NEOG) Director Sells 15,000 Shares of Stock” was first posted by Watch List News and is the property of of Watch List News. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/insider-selling-neogen-co-neog-director-sells-15000-shares-of-stock/3020060.html.

About Neogen

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Featured Article: Stock Symbol

Insider Buying and Selling by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.